Literature DB >> 16391818

Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells.

Hiroshige Hibasami1, Hirosi Iwase, Kazumi Yoshioka, Hidehisa Takahashi.   

Abstract

We have investigated the effect of glycyrrhetic acid (GR) which is metabolic substance of glycyrrhizin, on DNA of human hepatoma (HLE), promyelotic leukemia (HL-60) and stomach cancer (KATO III) cells. GR displayed apoptotic effects against HLE, HL-60 and KATO III cells. The fragmentation of DNA by GR to oligonucleosomal-sized fragments, a characteristic of apoptosis, was dose- and time-dependent in these cell lines. These findings suggest that growth inhibition of these cell lines by GR result from the induction of apoptosis by the compound. Inhibitors of caspases did not suppress the DNA fragmentation caused by GR. N-acetyl-L-cysteine, an antioxidant drug, weakly inhibited the DNA fragmentation caused by GR suggesting that active oxidants work partly as an apoptosis-inducing transfer substance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391818

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  33 in total

1.  Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cells.

Authors:  Venus Haghshenas; Shohreh Fakhari; Sako Mirzaie; Mohammadreza Rahmani; Fariba Farhadifar; Sara Pirzadeh; Ali Jalili
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Can licorice lick colon cancer?

Authors:  Paul M Stewart; Stephen M Prescott
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

3.  The renoprotective effect of glycyrrhizic acid in insulin-resistant rats exposed to aluminum involves the inhibition of TLR4/NF-κB signaling pathway.

Authors:  Noha A Emara; Mona F Mahmoud; Hassan M El Fayoumi; Amr A A Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-09       Impact factor: 3.000

4.  High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.

Authors:  Ruochan Chen; Shan Zhu; Xue-Gong Fan; Haichao Wang; Michael T Lotze; Herbert J Zeh; Timothy R Billiar; Rui Kang; Daolin Tang
Journal:  Hepatology       Date:  2018-04-01       Impact factor: 17.425

5.  Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.

Authors:  Latanya M Scott; Liwei Chen; Kenyon G Daniel; Wesley H Brooks; Wayne C Guida; Harshani R Lawrence; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Bioorg Med Chem Lett       Date:  2010-12-04       Impact factor: 2.823

Review 6.  Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.

Authors:  Yuewen Gong
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

7.  Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change.

Authors:  Doo Eung Kim; Young Chul Youn; Young Ki Kim; Ki Moo Hong; Chung Soo Lee
Journal:  Neurochem Res       Date:  2009-02-18       Impact factor: 3.996

8.  Growth inhibitory in vitro effects of glycyrrhizic acid in U251 glioblastoma cell line.

Authors:  Song Li; Jian-Hong Zhu; Li-Ping Cao; Qing Sun; Huan-Dong Liu; Wei-De Li; Jin-Song Li; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2014-02-11       Impact factor: 3.307

9.  18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.

Authors:  Jae Chon Yang; Soon Chul Myung; Wonyong Kim; Chung Soo Lee
Journal:  Mol Cell Biochem       Date:  2012-08-04       Impact factor: 3.396

10.  18beta-glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway.

Authors:  Di Wang; Hei-Kiu Wong; Yi-Bin Feng; Zhang-Jin Zhang
Journal:  J Neurooncol       Date:  2013-10-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.